There have been plenty of multi-billion-dollar mega mergers in the past few years but most have fallen short of their goals. In the latest edition of the BioWorld Insider podcast, Karen Carey, BioWorld’s senior managing editor and chief analyst, unpacked the details in 21 of the biggest M&As and found very few have turned out to be good deals for the buyer.